BSX vs NAUT · P/E 20, rev $10.65B vs $103.4M cap
Boston Scientific Corp (BSX) versus Nautilus Biotechnology Inc (NAUT) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Nautilus Biotechnology Inc (NAUT) is a biotechnology company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
NAUT does not have a complete income-statement cache yet.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. NAUT currently screens at market cap $103.4M.
Not investment advice. Open the BSX and NAUT stock pages for the full models.
Not investment advice.